Skip to main content
. 2015 Jun 23;9:1109–1116. doi: 10.2147/OPTH.S84207

Figure 3.

Figure 3

Spectral-domain optical coherence tomography at preimplantation and 5 months following bilateral implantation of sustained-release dexamethasone intravitreal implants in patient diagnosed with Vogt–Koyanagi–Harada syndrome.

Notes: Spectral-domain optical coherence tomography at Preimplantation of dexamethasone 0.7 mg in (A) right and (B) left eye, showing massive subretinal fluid, left more than right, with cystic change in both eyes, and bilateral improvement 5 months following implantation in (C) right and (D) left eye of patient 10.